Clinical Trial Update: Safety & Efficacy of Peg-ASP-based CCRT in Early Stage ENKTL [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the safety and efficacy of Peg-asparaginase-based concurrent chemoradiotherapy in early-stage Extranodal NK/T-cell lymphoma …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extranodal Nk T-cell Lymphoma Nasal Type

Drugs mentioned

• Pegaspargase (pegaspargase)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Extranodal NK/T-cell Lymphoma | Phase 2 | Status: RECRUITING